will cigna cover glp 1 for weight loss Health insurer stop covering GLP-1 drugs in its employee health plan Cigna (CI) to End Coverage

Scott Gottlieb, the FDAs former commissioner, said on CNBC that many of the compounds wont deliver the expected benefit. The agencys safety concerns appear to be well founded: between February 2019 and December 2023, the FDA received 352 adverse event reports related to compounded GLP-1 drugs, including five deaths

Clinical effects of glucagon-like peptide-1 agonist use for weight loss in women with polycystic ovary syndrome: a scoping review

T3, triiodothyronine

Chief Financial Officer Karsten Munk Knudsen guided 2025 sales growth of 13% to 21% at constant exchange rates, stating the outlook assumed a reduction in patients on compounded GLP-1 treatments in the second half of 2025